Pri-Med Southwest

Houston, TX | May 1-3, 2019

George R. Brown Convention Center

Disease Spotlight: The Pharmacotherapy of Alcohol and Opioid Use Disorders


In the U.S., about 15.1 million people have an alcohol use disorder and about 4.8 million misuse opioids. This session focuses on the pharmacotherapy of alcohol and opioid use disorders. The faculty will describe and contrast naltrexone and acamprosate treatments for alcohol use disorder and discuss the use of buprenorphine/naloxone to treat opioid use disorder.

Learning Objectives

Describe and contrast the mechanism of action of naltrexone and acamprosate in the treatment of alcohol use disorder

Use buprenorphine/naloxone to treat opioid use disorder


Download a PDF of Presented Slides



Petros Levounis, MD, MA

Petros Levounis, MD, MA, is professor and chair of the Department of Psychiatry at Rutgers New Jersey Medical School and chief of service at University Hospital in Newark, New Jersey. Dr. Levounis came to Rutgers from Columbia University, where he se...

View Full Bio